← Back to headlines

Eli Lilly's Weight-Loss Pill Approved in Europe, Novo Nordisk Maintains Lead
Eli Lilly and Company's weight-loss pill has secured its initial approval in Europe. Despite this milestone, Novo Nordisk A/S continues to hold a dominant position in the weight-loss drug market.
17 Aug, 14:34 — 17 Aug, 14:34
Sources
Showing 1 of 1 sources
